Publications by authors named "Peter Joy"

Claim this Profile
E
Evaluation of machine learning algorithms for predicting direct-acting antiviral treatment failure among patients with chronic hepatitis C infection.
Haesuk Park, Wei-Hsuan Lo-Ciganic, James Huang, Yonghui Wu, Linda Henry, Joy Peter

Sci Rep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustainable and equivalent improvements in symptoms and functional well-being following viral cure from ledipasvir/sofosbuvir versus elbasvir/grazoprevir for chronic hepatitis C infection: Findings from the randomized PRIORITIZE trial.
Donna M Evon, Meichen Dong, Bryce B Reeve, Joy Peter, Larry Michael

J Viral Hepat· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning algorithms for predicting direct-acting antiviral treatment failure in chronic hepatitis C: An HCV-TARGET analysis.
Haesuk Park, Wei-Hsuan Lo-Ciganic, James Huang, Yonghui Wu, Linda Henry, Joy Peter

Hepatology· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study.
Mark S Sulkowski, Juhi S Moon, Kenneth E Sherman, Giuseppe Morelli, Jama M Darling, Joy Peter

Hepatology· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linkage of resistance-associated substitutions in GT1 sofosbuvir + NS5A inhibitor failures treated with glecaprevir/pibrentasvir.
Gary P Wang, Gretja L Schnell, Jens J Kort, Gurjit S Sidhu, Layla Schuster, Joy A Peter

J Hepatol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy.
Anna S Lok, Mark S Sulkowski, Jens J Kort, Ira Willner, K Rajender Reddy, Joy A Peter

Gastroenterology· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection.
Gary P Wang, Norah Terrault, Jacqueline D Reeves, Lin Liu, Eric Li, Joy Peter

Sci Rep· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Public-Private Partnership: Targeting Real-World Data for Hepatitis C Direct-Acting Antivirals.
Poonam Mishra, Jeffry Florian, Joy Peter, Monika Vainorius, Michael W Fried

Gastroenterology· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus: how to provide the best treatment with what I have.
David R Nelson, Joy Peter

Liver Int· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET.
Stuart C Gordon, Andrew J Muir, Joseph K Lim, Brian Pearlman, Curtis K Argo, Joy Peter

J Hepatol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal interferon-free therapy in treatment-experienced chronic hepatitis C patients.
Joy Peter, David R Nelson

Liver Int· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New therapeutic strategies in HCV: second-generation protease inhibitors.
Virginia C Clark, Joy A Peter, David R Nelson

Liver Int· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial.
Manal F Abdelmalek, Schuyler O Sanderson, Paul Angulo, Consuelo Soldevila-Pico, Chen Liu, Joy Peter

Hepatology· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C in adults and adolescents with hemophilia: a randomized, controlled trial of interferon alfa-2b and ribavirin.
Michael W Fried, Joy Peter, Keith Hoots, Paul J Gaglio, Donald Talbut

Hepatology· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-time assessment of pain behavior during clinical assessment of low back pain patients.
Kenneth M Prkachin, Elizabeth Hughes, Izabela Schultz, Peter Joy, David Hunt

Pain· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis